Envoy Medical Statistics

Total Valuation

Envoy Medical has a market cap or net worth of $43.01 million. The enterprise value is $53.21 million.

Market Cap	43.01M
Enterprise Value	53.21M

Important Dates

The next estimated earnings date is Friday, November 15, 2024, after market close.

Earnings Date	Nov 15, 2024
Ex-Dividend Date	n/a

Share Statistics

Envoy Medical has 19.73 million shares outstanding. The number of shares has decreased by -87.57% in one year.

Current Share Class	19.73M
Shares Outstanding	19.73M
Shares Change (YoY)	-87.57%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	40.60%
Owned by Institutions (%)	7.57%
Float	7.19M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	134.55
Forward PS	90.32
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	176.19
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.62

Current Ratio	0.62
Quick Ratio	0.24
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-118.32

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-266.32%
Return on Capital (ROIC)	n/a
Revenue Per Employee	$8,882
Profits Per Employee	-$481,059
Employee Count	34
Asset Turnover	0.06
Inventory Turnover	0.59

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +103.81% in the last 52 weeks. The beta is 2.36, so Envoy Medical's price volatility has been higher than the market average.

Beta (5Y)	2.36
52-Week Price Change	+103.81%
50-Day Moving Average	2.95
200-Day Moving Average	3.18
Relative Strength Index (RSI)	33.69
Average Volume (20 Days)	632,132

Short Selling Information

The latest short interest is 44,111, so 0.22% of the outstanding shares have been sold short.

Short Interest	44,111
Short Previous Month	57,955
Short % of Shares Out	0.22%
Short % of Float	0.61%
Short Ratio (days to cover)	1.04

Income Statement

In the last 12 months, Envoy Medical had revenue of $302,000 and -$16.36 million in losses. Loss per share was -$0.95.

Revenue	302,000
Gross Profit	-548,000
Operating Income	-19.88M
Pretax Income	-23.04M
Net Income	-16.36M
EBITDA	-19.73M
EBIT	-19.88M
Loss Per Share	-$0.95

Full Income Statement

Balance Sheet

The company has $1.75 million in cash and $8.59 million in debt, giving a net cash position of -$6.84 million or -$0.35 per share.

Cash & Cash Equivalents	1.75M
Total Debt	8.59M
Net Cash	-6.84M
Net Cash Per Share	-$0.35
Equity (Book Value)	-12.39M
Book Value Per Share	-0.63
Working Capital	-3.06M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$21.36 million and capital expenditures -$440,000, giving a free cash flow of -$21.80 million.

Operating Cash Flow	-21.36M
Capital Expenditures	-440,000
Free Cash Flow	-21.80M
FCF Per Share	-$1.11

Full Cash Flow Statement

Margins

Gross Margin	-181.46%
Operating Margin	-6,582.12%
Pretax Margin	-4,511.92%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-7,266.81%

Dividends & Yields

Envoy Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	87.57%
Shareholder Yield	87.57%
Earnings Yield	-35.27%
FCF Yield	-47.02%

Analyst Forecast

The average price target for Envoy Medical is $7.92, which is 263.30% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$7.92
Price Target Difference	263.30%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Envoy Medical has an Altman Z-Score of -58.13 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-58.13
Piotroski F-Score	2